WallStreetZenWallStreetZen

NASDAQ: SNOA
Sonoma Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SNOA stock forecasts and price targets.

Forecast return on equity

Is SNOA forecast to generate an efficient return?

Company
-16.76%
Industry
32%
Market
67.24%
SNOA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SNOA forecast to generate an efficient return on assets?

Company
-5.4%
Industry
14.07%
SNOA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SNOA earnings per share forecast

What is SNOA's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.32
Avg 2 year Forecast
-$0.45

SNOA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
SNOA$3.68N/AN/A
SXTC$1.67N/AN/A
CPHI$1.70N/AN/A
SBFM$1.51N/AN/A
EVOK$5.13N/AN/A
View Top Pharmaceutical Stocks

Sonoma Pharmaceuticals Stock Forecast FAQ

What is SNOA's earnings growth forecast for 2026-2027?

(NASDAQ: SNOA) Sonoma Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 43.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.12%.

Sonoma Pharmaceuticals's earnings in 2025 is -$3,457,000.On average, 1 Wall Street analyst forecast SNOA's earnings for 2026 to be -$2,168,450, with the lowest SNOA earnings forecast at -$2,168,450, and the highest SNOA earnings forecast at -$2,168,450.

In 2027, SNOA is forecast to generate -$739,244 in earnings, with the lowest earnings forecast at -$739,244 and the highest earnings forecast at -$739,244.

If you're new to stock investing, here's how to buy Sonoma Pharmaceuticals stock.

What is SNOA's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SNOA) forecast ROE is -16.76%, which is considered weak.

What is SNOA's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SNOA) Sonoma Pharmaceuticals's current Earnings Per Share (EPS) is -$2.79. On average, analysts forecast that SNOA's EPS will be -$1.32 for 2026, with the lowest EPS forecast at -$1.32, and the highest EPS forecast at -$1.32. In 2027, SNOA's EPS is forecast to hit -$0.45 (min: -$0.45, max: -$0.45).

What is SNOA's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SNOA) forecast ROA is -5.4%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 14.07%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.